• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Galectin Therapeutics, Inc. (GALT)

    -NasdaqCM
    3.64 0.06(1.62%) Dec 19, 4:00PM EST
    Add to Portfolio
    Balance SheetGet Balance Sheet for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Assets
    Current Assets
    Cash And Cash Equivalents10,489  9,364  6,397  
    Short Term Investments -   -   -  
    Net Receivables -   -   -  
    Inventory -   -   -  
    Other Current Assets198  153  104  
    Total Current Assets 10,687   9,517   6,501  
    Long Term Investments -   -   -  
    Property Plant and Equipment3  8  6  
    Goodwill -   -   -  
    Intangible Assets23  30  36  
    Accumulated Amortization -   -   -  
    Other Assets -  6  69  
    Deferred Long Term Asset Charges -   -   -  
    Total Assets 10,713   9,561   6,612  
    Liabilities
    Current Liabilities
    Accounts Payable2,486  1,638  2,015  
    Short/Current Long Term Debt -   -   -  
    Other Current Liabilities -   -  200  
    Total Current Liabilities 2,486   1,638   2,215  
    Long Term Debt -   -   -  
    Other Liabilities -  6   -  
    Deferred Long Term Liability Charges -   -   -  
    Minority Interest -   -   -  
    Negative Goodwill -   -   -  
    Total Liabilities 2,486   1,644   2,215  
    Stockholders' Equity
    Misc Stocks Options Warrants -   -   -  
    Redeemable Preferred Stock6,746  6,752  6,522  
    Preferred Stock587  632  632  
    Common Stock18  16  13  
    Retained Earnings(101,965)(80,018)(69,137)
    Treasury Stock -   -   -  
    Capital Surplus102,841  80,535  66,367  
    Other Stockholder Equity -   -   -  
    Total Stockholder Equity 1,481   1,165   (2,125)
    Net Tangible Assets 1,458   1,135   (2,161)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.